Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Michael Moyle

Showing results (11-20 of 12) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 12 results.
Drug Discovery Today|March 30, 2021
Sortase A (SrtA) inhibitors as an alternative treatment for superbug infectionsSitah Alharthi, Seyed Ebrahim Alavi, Peter Michael Moyle, et al.
Bioconjugate Chemistry|June 17, 2020
Optimized Methods for the Production and Bioconjugation of Site-Specific, Alkyne-Modified Glucagon-like Peptide-1 (GLP-1) Analogs to Azide-Modified Delivery Platforms Using Copper-Catalyzed Alkyne-Azide CycloadditionSeyed Ebrahim Alavi, Peter John Cabot, Gee Yi Yap, et al.
Pageof 2

Showing results (11-20 of 12) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 12 results.
Drug Discovery Today|March 30, 2021
Sortase A (SrtA) inhibitors as an alternative treatment for superbug infectionsSitah Alharthi, Seyed Ebrahim Alavi, Peter Michael Moyle, et al.
Bioconjugate Chemistry|June 17, 2020
Optimized Methods for the Production and Bioconjugation of Site-Specific, Alkyne-Modified Glucagon-like Peptide-1 (GLP-1) Analogs to Azide-Modified Delivery Platforms Using Copper-Catalyzed Alkyne-Azide CycloadditionSeyed Ebrahim Alavi, Peter John Cabot, Gee Yi Yap, et al.
Pageof 2